Your browser doesn't support javascript.
loading
Disease-modifying effect and long-term safety of belimumab in patients with systemic lupus erythematosus: A single-center retrospective study.
Nakai, Takehiro; Fukui, Sho; Sawada, Haruki; Ikada, Yukihiko; Tamaki, Hiromichi; Kishimoto, Mitsumasa; Okada, Masato.
Afiliação
  • Nakai T; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.
  • Fukui S; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.
  • Sawada H; Center for Clinical Epidemiology, St Luke's International University, Tokyo, Japan.
  • Ikada Y; Department of Emergency and General Medicine, Kyorin University School of Medicine, Tokyo, Japan.
  • Tamaki H; Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, MA, USA.
  • Kishimoto M; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.
  • Okada M; Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Lupus ; 32(13): 1518-1527, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37858981
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article